S3 Ep5: A Tale of Two Misdiagnoses
Cancer Horizons22 Jan 2020

S3 Ep5: A Tale of Two Misdiagnoses

Learning of one’s increased risk for cancer can be an overwhelming experience, but imagine also being told of the wrong results from your genetic testing. Maureen Boesen and Connie Busch are forever connected to one another. After they participated in a genetics study at Creighton University led by Dr. Henry Lynch in the mid-1990s, both of their test results actually came back wrong. Maureen, who tested BRCA-positive and underwent preventive surgeries, was in fact negative for the genetic mutation, while Connie tested negative and only learned much later she was actually positive with an increased risk for cancer. In this week’s episode, we feature a conversation between the pair, who discussed the revelation that changed both of their lives. “Is there any advice that you would offer?” Maureen asked. “Don't be afraid of information,” Connie responded. “For me, knowing is better than not knowing. Sticking your head in the sand is not going to get you anywhere. If you have the information upfront, you're making the decision, you’re not letting cancer make that decision for you.” Maureen agreed, adding “For you, your family, your children and their children. It goes far beyond just us.”

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(295)

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Dec 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Mars 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Sep 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Mars 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Mars 202410min

S6 Ep20: FDA Approvals from February 2024

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Feb 20246min

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tum...

19 Feb 20249min

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered researc...

12 Feb 20247min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
medicinvetarna
svd-nyhetsartiklar
bildningspodden
det-morka-psyket
rss-ufobortom-rimligt-tvivel
rss-spraket
rss-vetenskapsradion
rss-vetenskapsradion-2
sexet
rss-broccolipodden-en-podcast-som-inte-handlar-om-broccoli
rss-kriminologerna
dumforklarat
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
vetenskapsradion
rss-lara-fran-larda-en-fackbok-och-en-forfattare
doden-hjarnan-kemisten